Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Y3ME
|
||||
| Former ID |
DAP000062
|
||||
| Drug Name |
Oxaliplatin
|
||||
| Synonyms |
Eloxatin (TN); Medac (TN); Oxaliplatin (TN); Oxaliplatin (JAN/USAN/INN)
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Anticancer Agents
|
||||
| Company |
Sanofi-Aventis
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C8H14N2O4Pt
|
||||
| Canonical SMILES |
C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2]
|
||||
| InChI |
1S/C6H14N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-6H,1-4,7-8H2;(H,3,4)(H,5,6);/q;;+2/p-2/t5-,6-;;/m1../s1
|
||||
| InChIKey |
ZROHGHOFXNOHSO-BNTLRKBRSA-L
|
||||
| CAS Number |
CAS 61825-94-3
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
7848852, 14854529, 14903423, 24173438, 45633994, 57373686, 78790585, 125309438, 127301221, 127301222, 127301223, 127301224, 127301225, 127301226, 127301227, 127301228, 127301229, 127301230, 127301231, 127301232, 127301233, 127301234, 127301235, 127301236, 127301237, 127301238, 127301239, 127301240, 127301241, 127301242, 127301243, 127301244, 127301245, 127301246, 135684119, 137001870, 152059544, 162036207, 164196639, 174477519, 226396770, 251885690, 252156659, 252316548
|
||||
| ChEBI ID |
ChEBI:31941
|
||||
| SuperDrug ATC ID |
L01XA03
|
||||
| SuperDrug CAS ID |
cas=061825943
|
||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Modulator | ||
| References | |||||
| Ref 537362 | The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer. Gan To Kagaku Ryoho. 2009 May;36(5):797-801. | ||||
| Ref 542456 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7433). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.